Changeflow GovPing Healthcare & Life Sciences Rani Therapeutics Pharmaceutical Polypeptide Co...
Routine Rule Added Final

Rani Therapeutics Pharmaceutical Polypeptide Compositions Patent EP3288543A1

Favicon for changeflow.com EPO Patent Bulletin - Pharma (A61K)
Published
Detected
Email

Summary

European Patent Office published patent application EP3288543A1 filed by Rani Therapeutics, LLC for pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins. The application was published on April 15, 2026 with inventors Imran Mir, Mercedes Morales, Radhika Korupolu, Elaine To, Joel Harris, and Mir Hashim. The patent covers IPC classifications A61K 9/20 and A61F 13/00 with designated states across European member states including Germany, France, United Kingdom, Italy, Spain, and 24 other European countries.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors EPO Patent Bulletin - Pharma (A61K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 72 changes logged to date.

What changed

The European Patent Office published application EP3288543A1 filed by Rani Therapeutics, LLC for pharmaceutical compositions and methods relating to solid masses comprising polypeptides and/or proteins. This is a publication of a patent application (Kind A1) rather than a granted patent, establishing priority rights for the invention in designated European member states.

Competitors in the pharmaceutical and biotechnology sectors should review the published claims for potential freedom-to-operate implications when developing similar polypeptide-based compositions. The application being publicly available means third parties can now assess the scope of protection sought and identify potential prior art.

Archived snapshot

Apr 25, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

PHARMACEUTICAL COMPOSITIONS AND METHODS FOR FABRICATION OF SOLID MASSES COMPRISING POLYPEPTIDES AND/OR PROTEINS

Publication EP3288543A1 Kind: A1 Apr 15, 2026

Applicants

Rani Therapeutics, LLC

Inventors

IMRAN, Mir, MORALES, Mercedes, KORUPOLU, Radhika, TO, Elaine, HARRIS, Joel, HASHIM, Mir

IPC Classifications

A61K 9/20 20060101AFI20181009BHEP A61F 13/00 20060101ALI20181009BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Pharma (A61K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 15th, 2026
Instrument
Rule
Branch
International
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP3288543A1

Who this affects

Applies to
Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent application Pharmaceutical research Biologics development
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals

Get alerts for this source

We'll email you when EPO Patent Bulletin - Pharma (A61K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!